Naoyoshi Ishikawa

666 total citations
7 papers, 547 citations indexed

About

Naoyoshi Ishikawa is a scholar working on Clinical Biochemistry, Pathology and Forensic Medicine and Cell Biology. According to data from OpenAlex, Naoyoshi Ishikawa has authored 7 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Clinical Biochemistry, 3 papers in Pathology and Forensic Medicine and 3 papers in Cell Biology. Recurrent topics in Naoyoshi Ishikawa's work include Advanced Glycation End Products research (4 papers), Alcohol Consumption and Health Effects (3 papers) and Aldose Reductase and Taurine (2 papers). Naoyoshi Ishikawa is often cited by papers focused on Advanced Glycation End Products research (4 papers), Alcohol Consumption and Health Effects (3 papers) and Aldose Reductase and Taurine (2 papers). Naoyoshi Ishikawa collaborates with scholars based in Japan, Belgium and United States. Naoyoshi Ishikawa's co-authors include Charles van Ypersele de Strihou, Toshio Miyata, Kiyoshi Kurokawa, Masaomi Nangaku, Reiko Inagi, Yasuhiko Ueda, Hiroshi Onogi, Kohji Ichimori, Hiroko Yuzawa and Toshio Sada and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and American Journal of Kidney Diseases.

In The Last Decade

Naoyoshi Ishikawa

7 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Naoyoshi Ishikawa Japan	7	287	170	167	104	87	7	547
M Luciak Poland	14	129 0.4×	148 0.9×	91 0.5×	42 0.4×	141 1.6×	48	562
Toshimitsu Niwa Japan	11	200 0.7×	300 1.8×	86 0.5×	29 0.3×	124 1.4×	12	670
Kazuyuki Hayashi Japan	6	164 0.6×	222 1.3×	108 0.6×	30 0.3×	69 0.8×	9	634
D Sandler United States	6	96 0.3×	83 0.5×	107 0.6×	35 0.3×	68 0.8×	11	451
R. Reitano Italy	14	559 1.9×	70 0.4×	284 1.7×	53 0.5×	200 2.3×	17	834
Valeria Berruti Italy	9	75 0.3×	121 0.7×	93 0.6×	161 1.5×	32 0.4×	11	427
Vladimír Jakuš Slovakia	11	277 1.0×	36 0.2×	212 1.3×	27 0.3×	97 1.1×	20	533
Stamatina Agalou United Kingdom	6	614 2.1×	114 0.7×	265 1.6×	23 0.2×	205 2.4×	10	773
Tomoyuki Katsuzaki Japan	10	409 1.4×	109 0.6×	179 1.1×	12 0.1×	135 1.6×	13	611
Yoshitada Yajima Japan	12	66 0.2×	90 0.5×	239 1.4×	52 0.5×	74 0.9×	28	504

Countries citing papers authored by Naoyoshi Ishikawa

Since Specialization

Citations

This map shows the geographic impact of Naoyoshi Ishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoyoshi Ishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoyoshi Ishikawa more than expected).

Fields of papers citing papers by Naoyoshi Ishikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoyoshi Ishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoyoshi Ishikawa. The network helps show where Naoyoshi Ishikawa may publish in the future.

Co-authorship network of co-authors of Naoyoshi Ishikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Naoyoshi Ishikawa. A scholar is included among the top collaborators of Naoyoshi Ishikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoyoshi Ishikawa. Naoyoshi Ishikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Izuhara, Yuko, Toshio Miyata, Kazuhiro Saito, et al.. (2004). Ultrapure dialysate decreases plasma pentosidine, a marker of “carbonyl stress”. American Journal of Kidney Diseases. 43(6). 1024–1029. 34 indexed citations

Jin, Jiye, Yasutada Suzuki, Naoyoshi Ishikawa, & Toyohide Takeuchi. (2004). A Miniaturized FIA System for the Determination of Residual Chlorine in Environmental Water Samples. Analytical Sciences. 20(1). 205–207. 44 indexed citations

Ishikawa, Naoyoshi, Toshio Miyata, Yasuhiko Ueda, et al.. (2003). Affinity adsorption of glucose degradation products improves the biocompatibility of conventional peritoneal dialysis fluid. Kidney International. 63(1). 331–339. 17 indexed citations

Nangaku, Masaomi, Toshio Miyata, Toshio Sada, et al.. (2003). Anti-Hypertensive Agents Inhibit In Vivo the Formation of Advanced Glycation End Products and Improve Renal Damage in a Type 2 Diabetic Nephropathy Rat Model. Journal of the American Society of Nephrology. 14(5). 1212–1222. 149 indexed citations

Miyata, Toshio, Naoyoshi Ishikawa, & Charles van Ypersele de Strihou. (2003). Carbonyl Stress and Diabetic Complications. Clinical Chemistry and Laboratory Medicine (CCLM). 41(9). 1150–8. 38 indexed citations

Komeda, Hidenobu, Naoyoshi Ishikawa, & Yasuhisa Asano. (2003). Enhancement of the thermostability and catalytic activity of d-stereospecific amino-acid amidase from Ochrobactrum anthropi SV3 by directed evolution. Journal of Molecular Catalysis B Enzymatic. 21(4-6). 283–290. 26 indexed citations

Miyata, Toshio, Charles van Ypersele de Strihou, Yasuhiko Ueda, et al.. (2002). Angiotensin II Receptor Antagonists and Angiotensin-Converting Enzyme Inhibitors Lower In Vitro the Formation of Advanced Glycation End Products. Journal of the American Society of Nephrology. 13(10). 2478–2487. 239 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact